Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Chromogenic Agar Medium Identifies Aeromonas in Fecal Samples

By LabMedica International staff writers
Posted on 25 Jun 2012
Chromogenic agar medium has been found useful for the isolation, differentiation, and potential identification of Aeromonas spp. More...
isolated from several sources.

Chromogenic media have facilitated the identification of pathogenic organisms at the genus level and in some cases at the species level, thus requiring a shorter testing time and simplifying the detection of target bacteria and the interpretation of primary culture results.

Medical microbiologists at National Polytechnic Institute (México) evaluated the microbiological performance of a chromogenic agar medium, using the Miles and Misra method and the Mossel ecometric technique. A total of 62 strains were tested, including 23 isolated from gastrointestinal infection, 13 type strains from the Spanish type culture collection of the Aeromonas genus, 12 strains isolated from water, nine isolated from frozen fish, and six other strains from the American type culture collection.

The medium CromoCen AGN agar (BioCen; Havana, Cuba) was designed as a chromogenic agar medium for the rapid and simultaneous identification of Aeromonas and Pseudomonas and for the identification and/or enumeration of Salmonella, Escherichia coli, and coliform bacteria. Two control media, MacConkey (Bioxon; Mexico City, Mexico), and Ryan Aeromonas (Oxoid Ltd.; Basingstoke, UK) were used for the comparative evaluation using the ecometric test.

CromoCen AGN agar medium was also assessed for the potential identification of Aeromonas spp. in fecal samples that were collected from asymptomatic schoolchildren. Out of 106 processed stool cultures, five were putatively positive (4.7%) and identified as Aeromonas colonies. These five strains were pale or light green in color, and only four had evident proteolytic activity. The CromoCen AGN exhibited 94.73% sensitivity and 100% specificity for the various samples

The authors concluded that if the incidence of Aeromonas diarrhea in the patient population of a given laboratory is high, the routine use of CromoCen AGN agar medium is warranted. This agar has a relatively high plating efficiency for most strains, can simplify the initial genus identification prior to genetic identification. CromoCen AGN agar is useful for the inhibition of Gram-positive bacteria, is easy to use, is simple to interpret and suitable for the identification of the Aeromonas genus. However, due to the incidence of false negative results, it should not be used for species identification. The study was published online on April 27, 2012, in the Journal of Microbiological Methods.

Related Links:

National Polytechnic Institute
Bioxon
Oxoid Ltd.



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.